Investor

Ysios Capital

ysioscapital.com ↗ ·Barcelona ·Multi stage ·Actively investing

Ysios Capital is a leading Spanish venture capital firm founded in 2008 that finances innovative biotechnology, medical device, and life sciences companies developing novel therapies for unmet medical needs, from early stages through clinical development. It manages over €400 million across multiple funds (including the newly launched €100M InceptionBio fund for biotech company creation) and has backed 42 portfolio companies, with 19 products reaching market and 70+ in clinical development.

Portfolio
8
Team
24
AUM
~€400M
Rounds
7
SectorsBiotechnology, Medical devices, Gene therapy, Cell therapy, Oncology, Rare diseases VC MapSeries B

Profile updated 18 Jul 2026

Team

Antoni Ribas
Venture Partner
Arturo Urrios
Partner
Carlos Garcia-Echeverria
Venture Partner
Carlos Paya
Venture Partner
Cristina Garmendia
General Partner
David L. Lacey
Venture Partner
Guillem Laporta
Partner
Joan Perelló
Managing Partner
Jordi Xiol
Partner
Joël Jean-Mairet
Managing Partner
Julia Salaverría
Managing Partner
Karen Wagner
Managing Partner
Lance Berman
Venture Partner
—
Pamela Klein
Venture Partner
Thomas Harth
Partner
Almudena Méndez
Associate
Laura Argelich
Associate
Malgorzata Rogalska
Associate
Sriram Balusu
Associate
Catalina Cuchy
Executive Assistant
—
Iñigo López-Huerta
CFO
María Vega de Seoane
Controller
Míriam Cortés
Executive Assistant & Communications
Wen Wen Cheng
General Counsel and Head of ESG

Portfolio companies 8

Funding rounds 7

Anaconda Biomed · Series C · $56M
Anaconda Biomed was founded in Barcelona and also has an office in Marin, California. It raised $56M to complete the ATHENA pivotal IDE stud…
2026-09-23
Ona Therapeutics · Series B · €74.2M
IRB Barcelona spin-out closed an oversubscribed €74.2M Series B co-led by Columbus and Mérieux to take its first-in-class antibody-drug conj…
2026-06-04
SpliceBio · Series B · $135M
SpliceBio closed a $135M (about €118M) Series B co-led by new investors EQT Life Sciences and Sanofi Ventures, with Roche Venture Fund joini…
2025-06-11
Anaconda Biomed · Other · €3.6M
CDTI Innovación, through its Innvierte programme, agreed to co-invest €3.6M in neurovascular medtech Anaconda Biomed alongside existing shar…
2025-01-10
Minoryx Therapeutics · Series C · €51M
Barcelona-area orphan-drug developer Minoryx closed a €51M Series C co-led by Columbus Venture Partners and Caixa Capital Risc (no single le…
2022-05-31
SpliceBio · Series A · €50M
SpliceBio raised an oversubscribed €50M Series A for its protein-splicing platform, which uses engineered inteins from Princeton's Muir Lab …
2022-02-16
Aelix Therapeutics · Other · €1.858M
Aelix Therapeutics, which develops a therapeutic HIV vaccine, received €1.858M through a CDTI Innvierte co-investment: €880K from CDTI and €…
2021-09-15

News & media 9

Start typing to search across everything.
↑↓ navigate↵ openesc close